Meridian Clinical Research, LLC is a clinical research site located in Binghamton, New York, United States 13901.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Meridian Clinical Research, LLC has participated in 11 clinical trials with 3 currently active.
Therapeutic areas: Meningococcal Vaccine, SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2.
Sponsors: Pfizer, BioNTech SE, Eli Lilly and Company.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Meridian Clinical Research, LLC has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Meridian Clinical Research, LLC has 11 clinical trials on record, with 3 currently active. Their work covers Meningococcal Vaccine, SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2.
Yes — Meridian Clinical Research, LLC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.